Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01864746
Title A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (PENELOPE-B)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors German Breast Group
Indications

breast carcinoma

Therapies

Palbociclib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN | AUT

Facility Status City State Zip Country Details
NSABP Foundation Pittsburgh Pennsylvania 15212 United States Details
Contact: Australia and New Zealand Breast Cancer Trials Group Newcastle New South Wales PO Box 155 Australia Details
Contact: Austrian Breast & Colorectal Cancer Study Group Vienna 1090 Austria Details
Contact: NSABP Foundation Multiple Locations Canada Details
Contact: UNICANCER Paris 75654 France Details
Contact: German Breast Group Neu-Isenburg 63263 Germany Details
Contact: Cancer Trials Ireland Dublin 2 Ireland Details
Contact: Japan Breast Cancer Research Group Tokyo 103-0016 Japan Details
Contact: Korea Cancer Study Group Seoul 138-736 Korea, Republic of Details
GEICAM San Sebastián de los Reyes 28703 Spain Details
Contact: Institute of Cancer Research London SW7 3RP United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field